SOURCE-LINKED STUDY SUMMARY
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.
Abstract summarizedQuality not appraised
- What was studied
- SLU-PP-915, an orally active compound that activates energy-regulating ERR receptors, was tested for exercise-related effects.
- Who / model studied
- Preclinical experiments were reported. The abstract does not clearly specify the animals or sample size for the SLU-PP-915 experiments.
- Studied dose & schedule
- Dose and schedule were not reported in the source used for this summary.
- What the study found
- The compound increased exercise distance and duration. Activity was retained with oral delivery after accounting for exposure.
- Limitations & context
- The abstract presents SLU-PP-915 as a research tool for further study; it does not establish clinical benefits in people.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1016/j.jpet.2025.103787